您的位置:PharmaNews → 市场快讯 → 正文
内容搜索
热门内容
推荐内容
最新内容
反馈意见和建议

Access Pharmaceuticals to Host North American MuGard Commercialization Update Conference Call for Investors(2)
本文章共2195字,分2页,当前第2页,快速翻页:


 


  Contact: Company              Contact: Investor Relations
  ----------------              ---------------------------
                                  Donald C. Weinberger/Diana Bittner
  Christine Berni                (media)
  Director of Investor Relations Wolfe Axelrod Weinberger Assoc. LLC
  Access Pharmaceuticals, Inc.  (212) 370-4500
  (212) 786-6208

Source: Access Pharmaceuticals, Inc.

CONTACT: Christine Berni, Director of Investor Relations of Access
Pharmaceuticals, Inc., +1-212-786-6208; or Investor Relations, Donald C.
Weinberger/Diana Bittner (media) of Wolfe Axelrod Weinberger Assoc. LLC,
+1-212-370-4500, for Access Pharmaceuticals, Inc.
 

Web Site: http://www.accesspharma.com/

 

转载自pharmaLive


 

 

点这里复制本页地址     发送给您QQ/MSN上的好友


相关文章

•  MCOs Offering Both Medicare Advantage an

•  Sun Pharma: US Appeals Court Rules Gemza

•  Marketing Disease Prevention In America

•  Purdue Archives and Special Collections

Actient Pharmaceuticals, LLC Closes Tran

Health Secretary Urges All Pennsylvanian

Sanofi Pasteur Begins Shipping Influenza

GlaxoSmithKline Begins Distribution of F

Perrigo Confirms Filing for Generic Vers

全球气温飙升,清凉油出口井喷

相关评论

    
本文章所属分类:首页 → 市场快讯